Author:
DiMasi Joseph A.,Faden Laura B.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference17 articles.
1. Angell, M. The Truth About the Drug Companies: How They Deceive Us and What to Do About It (Random House, New York, 2004).
2. Hollis, A. Comment on “The economics of follow-on drug research and development: trends in entry rates and the timing of development”. Pharmacoeconomics 3, 1187–1192 (2005).
3. Werthheimer, A., Levy, R. & O'Connor, T. Too many drugs? The clinical and economic value of incremental innovations. Res. Hum. Cap. Dev. 14, 77–118 (2001).
4. Lu, Z. J. & Comanor, W. S. Strategic pricing of new pharmaceuticals. Rev. Econ. Stat. 80, 108–118 (2008).
5. Towse, A. & Leighton, T. in Risk and Return in the Pharmaceutical Industry (eds Sussex, J. & Marchant, N.) 91–105 (Office of Health Economics, London, 1999).
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献